Clinical trials
Completed Hepatitis C, Chronic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
692 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 6 |
| 2001 | 9 |
| 2002 | 16 |
| 2003 | 22 |
| 2004 | 26 |
| 2005 | 49 |
| 2006 | 37 |
| 2007 | 49 |
| 2008 | 42 |
| 2009 | 34 |
| 2010 | 24 |
| 2011 | 65 |
| 2012 | 63 |
| 2013 | 47 |
| 2014 | 33 |
| 2015 | 50 |
| 2016 | 40 |
| 2017 | 31 |
| 2018 | 18 |
| 2019 | 11 |
| 2020 | 9 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 692 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 82 |
| Hoffmann-La Roche | 76 |
| AbbVie | 70 |
| Gilead Sciences | 32 |
| Boehringer Ingelheim | 16 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 16 |
| Bristol-Myers Squibb | 11 |
| Tanabe Pharma Corporation | 11 |
| AbbVie (prior sponsor, Abbott) | 9 |
| Kirby Institute | 9 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C, Chronic | 692 |
| Hepatitis C | 248 |
| Fibrosis | 36 |
| Liver Diseases | 29 |
| Hepatitis | 26 |
| HIV Infections | 18 |
| Liver Cirrhosis | 18 |
| Acquired Immunodeficiency Syndrome | 15 |
| Virus Diseases | 15 |
| Hepatitis, Chronic | 13 |
Trials
Showing 76 to 100 of 692. Each trial links to its page on Pharma Observatory.
592 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.